Maureen Roden has served as Quince Therapeutics’ Vice President, Clinical Development since June 2022. To this role, she brings more than 30 years of drug development experience and executive leadership. Previously, Ms. Roden was a co-founder and served as Chief Executive Officer of Pancovax, Inc. from 2020 to 2022 and Chief Executive Officer of Luna Consulting from 2015 to 2021. Ms. Roden was the sole founder and Chief Executive Officer of BPSI, a biomedical consulting and government contracting company from 2006 to 2015. Under her leadership, BSPI revenue grew to $34 million. Ms. Roden also has consulted for multiple large and small pharmaceutical companies in the areas of clinical development, operations, and strategic positioning. Earlier in her career, she managed anti-infective clinical trials at the National Cancer Institute from 1994 to 2004. Ms. Roden holds a M.S.N. from Georgetown University and a B.S. in Nursing from University of Scranton.